Humulin L was a U100 r-DNA/GE/GM intermediate-acting, lente insulin. Novo Nordisk also made similar insulins, calling them Novolin L and Monotard. "L" came to an end when Eli Lilly announced in July, 2005 that it would no longer be produced. The UK & Euro production of Humulin L stopped a year prior to this, in July 2004.